← Back to Patent Explorer
US4511353A Expired / Lapsed US ⏱️ 0.0 years remaining

Intravenous system for delivering a beneficial agent

Assignee: Alza Corp
•
Filing: 1981-10-09
•
Granted: 1985-04-16
•
Expires: 2001-10-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A formulation chamber is disclosed comprising a wall surrounding a lumen containing a device for delivering a beneficial agent. The chamber has an inlet for admitting a fluid into the chamber and an outlet for letting an agent formulation leave the chamber. The chamber is adapted for use in an intravenous delivery system for delivering an agent formulation to a patient.

Inventors

  • 👤 Felix Theeuwes

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 18:01
CPC Classifications
A; A61; A61M; A61M5/00; A61M5/14; A61M5/1407

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 166 words
A self-contained, self-powered beneficial, drug delivery system for use with an intravenous delivery system, the beneficial drug delivery system, comprising in combination: (a) an intravenous formulation chamber comprising: a wall provided with an inlet that lets an intravenously acceptable medical fluid into the intravenous formulation chamber, and with an outlet for letting fluid leave the chamber; and, (b) a drug delivery device in the intravenous formulation chamber, the device comprising an inner mass transfer conductor; a beneficial intravenously administrable drug in an amount for performing a therapeutic program with said intravenously administrable drug in the conductor that is permeable to the passage of the drug; and, a membrane surrounding the conductor, which membrane release the drug in a therapeutically effective amount from the device into the medical fluid that is a pharmaceutically acceptable carrier for the drug and enters the intravenous, formulation chamber for formulating an intravenously administrable fluid drug formulation in situ that produces a beneficial effect, when administered intravenously to a recipient, over time.
Claim 2
Dependent Claim 166 words
A self-contained, self-powered beneficial, drug delivery system for use with an intravenous delivery system, the beneficial drug delivery system, comprising in combination: (a) an intravenous formulation chamber comprising: a wall provided with an inlet that lets an intravenously acceptable medical fluid into the intravenous formulation chamber, and with an outlet for letting fluid leave the chamber; and, (b) a drug delivery device in the intravenous formulation chamber, the device comprising an inner mass transfer conductor; a beneficial intravenously administrable drug in an amount for performing a therapeutic program with said intravenously administrable drug in the conductor that is permeable to the passage of the drug; and, a membrane surrounding the conductor, which membrane release the drug in a therapeutically effective amount from the device into the medical fluid that is a pharmaceutically acceptable carrier for the drug and enters the intravenous, formulation chamber for formulating an intravenously administrable fluid drug formulation in situ that produces a beneficial effect, when administered intravenously to a recipient, over time.
Claim 3
Dependent Claim 53 words
The beneficial drug delivery system for use with the intravenous delivery system according to claim 1, wherein when the chamber is connected to an intravenous delivery system, the device delivers the drug at a rate controlled by the device into the medical fluid that flows from the intravenous system into the formulation chamber.
Claim 4
Dependent Claim 24 words
The beneficial drug delivery system for use with the intravenous delivery system according to claim 1, wherein the mass transfer conductor is a solid.
Claim 5
Dependent Claim 24 words
The beneficial drug delivery system for use with the intravenous delivery system according to claim 1, wherein the mass transfer conductor is a liquid.
Claim 6
Dependent Claim 34 words
The beneficial drug delivery system for use with the intravenous delivery system according to claim 1, wherein the membrane is a release rate controlling membrane that release the drug by the process of diffusion.
Claim 7
Dependent Claim 23 words
The beneficial drug delivery system for use with the intravenous delivery system according to claim 1, wherein the delivery device membrane is microporous.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-04-15 1988-10-15 1989-04-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-04-15 1992-10-15 1993-04-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-04-15 1996-10-15 1997-04-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag